BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 17721092)

  • 1. Concentrations of zidovudine- and lamivudine-triphosphate according to cell type in HIV-seronegative adults.
    Anderson PL; Zheng JH; King T; Bushman LR; Predhomme J; Meditz A; Gerber J; Fletcher CV
    AIDS; 2007 Sep; 21(14):1849-54. PubMed ID: 17721092
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intracellular nucleoside triphosphate concentrations in HIV-infected patients on dual nucleoside reverse transcriptase inhibitor therapy.
    Moore JD; Acosta EP; Johnson VA; Bassett R; Eron JJ; Fischl MA; Long MC; Kuritzkes DR; Sommadossi JP
    Antivir Ther; 2007; 12(6):981-6. PubMed ID: 17926654
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetic Modeling of Lamivudine and Zidovudine Triphosphates Predicts Differential Pharmacokinetics in Seminal Mononuclear Cells and Peripheral Blood Mononuclear Cells.
    Dumond JB; Yang KH; Kendrick R; Reddy YS; Kashuba AD; Troiani L; Bridges AS; Fiscus SA; Forrest A; Cohen MS
    Antimicrob Agents Chemother; 2015 Oct; 59(10):6395-401. PubMed ID: 26239974
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Simultaneous quantitation of the 5'-triphosphate metabolites of zidovudine, lamivudine, and stavudine in peripheral mononuclear blood cells of HIV infected patients by high-performance liquid chromatography tandem mass spectrometry.
    Moore JD; Valette G; Darque A; Zhou XJ; Sommadossi JP
    J Am Soc Mass Spectrom; 2000 Dec; 11(12):1134-43. PubMed ID: 11118121
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of HIV-1 infection and sex on the cellular pharmacology of the antiretroviral drugs zidovudine and lamivudine.
    Rower JE; Meditz A; Gardner EM; Lichtenstein K; Predhomme J; Bushman LR; Klein B; Zheng JH; Mawhinney S; Anderson PL
    Antimicrob Agents Chemother; 2012 Jun; 56(6):3011-9. PubMed ID: 22391541
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Simultaneous quantitation of intracellular zidovudine and lamivudine triphosphates in human immunodeficiency virus-infected individuals.
    Rodriguez JF; Rodriguez JL; Santana J; García H; Rosario O
    Antimicrob Agents Chemother; 2000 Nov; 44(11):3097-100. PubMed ID: 11036029
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intracellular pharmacokinetics of once versus twice daily zidovudine and lamivudine in adolescents.
    Flynn PM; Rodman J; Lindsey JC; Robbins B; Capparelli E; Knapp KM; Rodriguez JF; McNamara J; Serchuck L; Heckman B; Martinez J;
    Antimicrob Agents Chemother; 2007 Oct; 51(10):3516-22. PubMed ID: 17664328
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Zidovudine triphosphate and lamivudine triphosphate concentration-response relationships in HIV-infected persons.
    Fletcher CV; Kawle SP; Kakuda TN; Anderson PL; Weller D; Bushman LR; Brundage RC; Remmel RP
    AIDS; 2000 Sep; 14(14):2137-44. PubMed ID: 11061655
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Zidovudine phosphorylation in HIV-infected patients and seronegative volunteers.
    Barry M; Wild M; Veal G; Back D; Breckenridge A; Fox R; Beeching N; Nye F; Carey P; Timmins D
    AIDS; 1994 Aug; 8(8):F1-5. PubMed ID: 7986398
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antiviral dynamics and sex differences of zidovudine and lamivudine triphosphate concentrations in HIV-infected individuals.
    Anderson PL; Kakuda TN; Kawle S; Fletcher CV
    AIDS; 2003 Oct; 17(15):2159-68. PubMed ID: 14523272
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Determination of zidovudine triphosphate intracellular concentrations in peripheral blood mononuclear cells from human immunodeficiency virus-infected individuals by tandem mass spectrometry.
    Font E; Rosario O; Santana J; García H; Sommadossi JP; Rodriguez JF
    Antimicrob Agents Chemother; 1999 Dec; 43(12):2964-8. PubMed ID: 10582890
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Joint population pharmacokinetic analysis of zidovudine, lamivudine, and their active intracellular metabolites in HIV patients.
    Bazzoli C; Bénech H; Rey E; Retout S; Salmon D; Duval X; Tréluyer JM; Mentré F;
    Antimicrob Agents Chemother; 2011 Jul; 55(7):3423-31. PubMed ID: 21576446
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics of lamivudine and lamivudine-triphosphate after administration of 300 milligrams and 150 milligrams once daily to healthy volunteers: results of the ENCORE 2 study.
    Else LJ; Jackson A; Puls R; Hill A; Fahey P; Lin E; Amara A; Siccardi M; Watson V; Tjia J; Emery S; Khoo S; Back DJ; Boffito M
    Antimicrob Agents Chemother; 2012 Mar; 56(3):1427-33. PubMed ID: 22183172
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential extracellular and intracellular concentrations of zidovudine and lamivudine in semen and plasma of HIV-1-infected men.
    Dumond JB; Reddy YS; Troiani L; Rodriguez JF; Bridges AS; Fiscus SA; Yuen GJ; Cohen MS; Kashuba AD
    J Acquir Immune Defic Syndr; 2008 Jun; 48(2):156-62. PubMed ID: 18360288
    [TBL] [Abstract][Full Text] [Related]  

  • 15. AVANTI 2. Randomized, double-blind trial to evaluate the efficacy and safety of zidovudine plus lamivudine versus zidovudine plus lamivudine plus indinavir in HIV-infected antiretroviral-naive patients.
    AIDS; 2000 Mar; 14(4):367-74. PubMed ID: 10770538
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biphasic elimination of tenofovir diphosphate and nonlinear pharmacokinetics of zidovudine triphosphate in a microdosing study.
    Chen J; Flexner C; Liberman RG; Skipper PL; Louissaint NA; Tannenbaum SR; Hendrix CW; Fuchs EJ
    J Acquir Immune Defic Syndr; 2012 Dec; 61(5):593-9. PubMed ID: 23187888
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High levels of zidovudine (AZT) and its intracellular phosphate metabolites in AZT- and AZT-lamivudine-treated newborns of human immunodeficiency virus-infected mothers.
    Durand-Gasselin L; Pruvost A; Dehée A; Vaudre G; Tabone MD; Grassi J; Leverger G; Garbarg-Chenon A; Bénech H; Dollfus C
    Antimicrob Agents Chemother; 2008 Jul; 52(7):2555-63. PubMed ID: 18426897
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of a new cartridge radioimmunoassay for determination of intracellular levels of lamivudine triphosphate in the peripheral blood mononuclear cells of human immunodeficiency virus-infected patients.
    Robbins BL; Tran TT; Pinkerton FH; Akeb F; Guedj R; Grassi J; Lancaster D; Fridland A
    Antimicrob Agents Chemother; 1998 Oct; 42(10):2656-60. PubMed ID: 9756772
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Single-dose pharmacokinetics and safety of abacavir (1592U89), zidovudine, and lamivudine administered alone and in combination in adults with human immunodeficiency virus infection.
    Wang LH; Chittick GE; McDowell JA
    Antimicrob Agents Chemother; 1999 Jul; 43(7):1708-15. PubMed ID: 10390227
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intracellular pharmacokinetics of tenofovir diphosphate, carbovir triphosphate, and lamivudine triphosphate in patients receiving triple-nucleoside regimens.
    Hawkins T; Veikley W; St Claire RL; Guyer B; Clark N; Kearney BP
    J Acquir Immune Defic Syndr; 2005 Aug; 39(4):406-11. PubMed ID: 16010161
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.